Brief: Nymox Announces Submission Of New Drug Application (NDA) To The FDA For Fexapotide Triflutate
03/03/2022 17:27
Nymox Pharmaceutical Corp NYMX.O :
* NYMOX ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION (NDA)
TO THE
FDA FOR FEXAPOTIDE TRIFLUTATE
* NYMOX ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION (NDA)
TO FDA
FOR FEXAPOTIDE TRIFLUTATE
* NYMOX PHARMACEUTICAL - INTENDS TO SUBMIT APPLICATIONS IN
OTHER
MAJOR MARKETS IN NEAR TERM AND WILL PROVIDE UPDATES AT
APPROPRIATE TIMES IN DUE COURSE
Source text for Eikon: ID:nGNX9tZGqQ
Further company coverage: NYMX.O
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba